课题基金 / 基金详情

IGF::OT::IGF - CORE INFRASTRUCTURE SUPPORT

IGF::OT::IGF - CORE INFRASTRUCTURE SUPPORT
IGF::OT::IGF - 核心基础设施支持
批准号：
9553428
负责人：
HOWARD BAILEY
金额：
$81.62万
依托单位：
UNIVERSITY OF WISCONSIN-MADISON
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
项目状态：
已结题
起止时间：
2017-09-24 至 2018-09-23
来源：
https://reporter.nih.gov/project-details/9553428
关键词：
ClinicalClinical ChemopreventionClinical TrialsConduct Clinical TrialsContractorDataDevelopmentDivision of Cancer PreventionDrug IndustryFundingGuidelinesIndividualMaintenanceMalignant NeoplasmsMolecular TargetMonitorNational Cancer InstituteOutcomePerformancePhasePreventionPreventiveProtocols documentationRequest for ProposalsResearch InfrastructureSafetySiteSpecific qualifier valueTimeVisitcancer preventionclinically relevantdata managementinterestlaboratory experimentmeetingsprevention clinical trialprogramsprotocol development

项目摘要

项目成果

HOWARD BAILEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The National Cancer Institute (NCI), Division of Cancer Prevention (DCP) Phase 0/I/II Cancer Prevention Clinical Trials Program supports early clinical trials to rapidly evaluate the clinical activity and biologic effects of cancer preventive agents of interest to DCP. The agents to be studied shall include agents developed by the pharmaceutical industry and provided to DCP for collaborative development, commercially available agents, and agents developed by DCP. The objectives of this Task Order are to provide the core infrastructure to support the conduct of the clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
  • 批准号：
    10425188
  • 项目类别：
  • 资助金额：
    $70.73万
  • 财政年份：
    2021
  • 负责人：
    HOWARD BAILEY
  • 依托单位：
    UNIVERSITY OF WISCONSIN-MADISON
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
  • 批准号：
    10683047
  • 项目类别：
  • 资助金额：
    $10.75万
  • 财政年份：
    2021
  • 负责人：
    HOWARD BAILEY
  • 依托单位：
    UNIVERSITY OF WISCONSIN-MADISON
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
  • 批准号：
    10045662
  • 项目类别：
  • 资助金额：
    $82.22万
  • 财政年份：
    2019
  • 负责人：
    HOWARD BAILEY
  • 依托单位：
    UNIVERSITY OF WISCONSIN-MADISON
PILOT STUDY OF DAILY EXEMESTANE IN WOMEN WITH COMPLEX ATYPICAL HYPERPLASIA OF THE ENDOMETRIUM/ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA OR GRADE 1 ENDOMETRIAL CANCER
  • 批准号：
    10674471
  • 项目类别：
  • 资助金额：
    $29.66万
  • 财政年份：
    2017
  • 负责人：
    HOWARD BAILEY
  • 依托单位：
    UNIVERSITY OF WISCONSIN-MADISON
海外基金